255 related articles for article (PubMed ID: 29453754)
1. PACAP38 in human models of primary headaches.
Ashina H; Guo S; Vollesen ALH; Ashina M
J Headache Pain; 2017 Nov; 18(1):110. PubMed ID: 29453754
[TBL] [Abstract][Full Text] [Related]
2. Targeted Pituitary Adenylate Cyclase-Activating Peptide Therapies for Migraine.
Vollesen ALH; Amin FM; Ashina M
Neurotherapeutics; 2018 Apr; 15(2):371-376. PubMed ID: 29464574
[TBL] [Abstract][Full Text] [Related]
3. PACAP38: Emerging Drug Target in Migraine and Cluster Headache.
Vollesen ALH; Ashina M
Headache; 2017 May; 57 Suppl 2():56-63. PubMed ID: 28485845
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38.
Amin FM; Hougaard A; Schytz HW; Asghar MS; Lundholm E; Parvaiz AI; de Koning PJ; Andersen MR; Larsson HB; Fahrenkrug J; Olesen J; Ashina M
Brain; 2014 Mar; 137(Pt 3):779-94. PubMed ID: 24501094
[TBL] [Abstract][Full Text] [Related]
5. Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine.
Guo S; Vollesen AL; Hansen RD; Esserlind AL; Amin FM; Christensen AF; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):125-135. PubMed ID: 26994299
[TBL] [Abstract][Full Text] [Related]
6. Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients.
Guo S; Vollesen AL; Hansen YB; Frandsen E; Andersen MR; Amin FM; Fahrenkrug J; Olesen J; Ashina M
Cephalalgia; 2017 Feb; 37(2):136-147. PubMed ID: 26994298
[TBL] [Abstract][Full Text] [Related]
7. The role of genetics on migraine induction triggered by CGRP and PACAP38.
Guo S
Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603
[TBL] [Abstract][Full Text] [Related]
8. PACAP38 and PAC
Rubio-Beltrán E; Correnti E; Deen M; Kamm K; Kelderman T; Papetti L; Vigneri S; MaassenVanDenBrink A; Edvinsson L;
J Headache Pain; 2018 Aug; 19(1):64. PubMed ID: 30088106
[TBL] [Abstract][Full Text] [Related]
9. Investigation of carbachol and PACAP38 in a human model of migraine.
Schytz HW
Dan Med Bull; 2010 Dec; 57(12):B4223. PubMed ID: 21122466
[TBL] [Abstract][Full Text] [Related]
10. PACAP38 dose-response pilot study in migraine patients.
Vollesen AL; Guo S; Ashina M
Cephalalgia; 2017 Apr; 37(4):391-395. PubMed ID: 27084887
[TBL] [Abstract][Full Text] [Related]
11. Change in brain network connectivity during PACAP38-induced migraine attacks: A resting-state functional MRI study.
Amin FM; Hougaard A; Magon S; Asghar MS; Ahmad NN; Rostrup E; Sprenger T; Ashina M
Neurology; 2016 Jan; 86(2):180-7. PubMed ID: 26674334
[TBL] [Abstract][Full Text] [Related]
12. Targeting pituitary adenylate cyclase-activating polypeptide (PACAP) with monoclonal antibodies in migraine prevention: a brief review.
Rustichelli C; Lo Castro F; Baraldi C; Ferrari A
Expert Opin Investig Drugs; 2020 Nov; 29(11):1269-1275. PubMed ID: 32877252
[TBL] [Abstract][Full Text] [Related]
13. Early treatment with sumatriptan prevents PACAP38-induced migraine: A randomised clinical trial.
Wienholtz NKF; Christensen CE; Zhang DG; Coskun H; Ghanizada H; Al-Karagholi MA; Hannibal J; Egeberg A; Thyssen JP; Ashina M
Cephalalgia; 2021 May; 41(6):731-748. PubMed ID: 33567890
[TBL] [Abstract][Full Text] [Related]
14. Effect of the H
Vollesen LH; Guo S; Andersen MR; Ashina M
Cephalalgia; 2019 Apr; 39(5):597-607. PubMed ID: 30165750
[TBL] [Abstract][Full Text] [Related]
15. PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?
Hoffmann J; Miller S; Martins-Oliveira M; Akerman S; Supronsinchai W; Sun H; Shi L; Wang J; Zhu D; Lehto S; Liu H; Yin R; Moyer BD; Xu C; Goadsby PJ
Pain; 2020 Jul; 161(7):1670-1681. PubMed ID: 32142016
[TBL] [Abstract][Full Text] [Related]
16. PACAP38 induces migraine-like attacks in patients with migraine without aura.
Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M
Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139
[TBL] [Abstract][Full Text] [Related]
17. Premonitory and nonheadache symptoms induced by CGRP and PACAP38 in patients with migraine.
Guo S; Vollesen ALH; Olesen J; Ashina M
Pain; 2016 Dec; 157(12):2773-2781. PubMed ID: 27842045
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of PACAP in ischemia.
Reglodi D; Vaczy A; Rubio-Beltran E; MaassenVanDenBrink A
J Headache Pain; 2018 Mar; 19(1):19. PubMed ID: 29500688
[TBL] [Abstract][Full Text] [Related]
19. PACAP27 induces migraine-like attacks in migraine patients.
Ghanizada H; Al-Karagholi MA; Arngrim N; Olesen J; Ashina M
Cephalalgia; 2020 Jan; 40(1):57-67. PubMed ID: 31299857
[TBL] [Abstract][Full Text] [Related]
20. Chronic changes in pituitary adenylate cyclase-activating polypeptide and related receptors in response to repeated chemical dural stimulation in rats.
Han X; Ran Y; Su M; Liu Y; Tang W; Dong Z; Yu S
Mol Pain; 2017; 13():1744806917720361. PubMed ID: 28776455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
